Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

COBICISTAT vs COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

COBICISTAT vs COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR: Safety Overview

Metric COBICISTAT COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR
Total FAERS Reports 347 998
Deaths Reported 41 78
Death Rate 11.8% 7.8%
Hospitalizations 109 346
Average Patient Age 45.1 yrs 44.6 yrs
% Female Patients 40.9% 29.5%
FDA Approval Date Feb 7, 2024 N/A
Manufacturer Gilead Sciences, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A